Back to search

Fibrinolytic states in a patient with congenital deficiency of alpha 2- plasmin inhibitor

Data up to Jan 2025

Published1980
Citations60
References30

Total Citations Per Year

Abstract

References (30)

The Reliability of Molecular Weight Determinations by Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis

1969 • 20,498 citations

A new method for the determination of fibrinogen in small samples of plasma.

1951 • 1,004 citations

Quantitative Estimation of Split Products of Fibrinogen in Human Serum, Relation to Diagnosis and Treatment

1966 • 483 citations

Isolation and characterization of alpha2-plasmin inhibitor from human plasma. A novel proteinase inhibitor which inhibits activator-induced clot lysis.

1976 • 474 citations

Identification and Some Properties of a New Fast‐Reacting Plasmin Inhibitor in Human Plasma

1976 • 341 citations

Measurement of the binding of antifibrinolytic amino acids to various plasminogens

1972 • 308 citations

The primary inhibitor of plasmin in human plasma

1976 • 274 citations

Abnormal Plasminogen

1978 • 259 citations

Differences in the binding to fibrin of native plasminogen and plasminogen modified by proteolytic degradation influence of ω-aminocarboxylic acids

1975 • 250 citations

Characterization of human plasminogen II. Separation and partial characterization of different molecular forms of human plasminogen

1972 • 241 citations

Congenital Deficiency of α2-Plasmin Inhibitor Associated with Severe Hemorrhagic Tendency *

1979 • 201 citations

Differences in the Binding to Fibrin of Urokinase and Tissue Plasminogen Activator

1972 • 167 citations

Physico-chemical and proenzyme properties of NH2-terminal glutamic acid and NH2-terminal lysine human plasminogen

1974 • 158 citations

The behavior of alpha2-plasmin inhibitor in fibrinolytic states.

1977 • 156 citations

Degradation of Human Fibrinogen by Plasma α2-Macroglobulin-Enzyme Complexes

1973 • 156 citations

The α2-plasmin inhibitor levels in liver diseases

1978 • 102 citations

α2-PLASMIN-INHIBITOR DEFICIENCY (MIYASATO DISEASE)

1978 • 88 citations

Fast-acting plasmin inhibitor in human plasma

1978 • 82 citations

Natural inhibitors of fibrinolysis

1979 • 68 citations

Inhibition of plasminogen binding to fibrin by α2-plasmin inhibitor

1977 • 67 citations

Effects of alpha2-plasmin inhibitor on fibrin clot lysis. Its comparison with alpha2-macroglobulin.

1978 • 60 citations

Effects of α2-Plasmin Inhibitor on Fibrin Clot Lysis. Its Comparison with α2-Macroglobulin

1978 • 57 citations

Reversible and irreversible alterations of human plasminogen indicated by changes in susceptibility to plasminogen activators and in response to epsilon-aminocaproic acid.

1974 • 40 citations

The resistance of fibrinogen and soluble fibrin monomer in blood to degradation by a potent plasminogen activator derived from cadaver limbs

1975 • 36 citations

Inhibition of Proteases in Coagulation, Kinin-Forming and Complement Systems by α2-Plasmin Inhibitor

1977 • 22 citations

Properties of a partially purified preparation of a circulating plasminogen activator

1976 • 21 citations

The fibrinolytic system—Basic considerations

1979 • 17 citations

Calcium-dependent binding of α2-plasmin inhibitor to fibrin

1979 • 12 citations

Assessment of Plasma Fibrinolytic System with Use of Chromogenic Substrate

1978 • 9 citations

Radioimmunoassay of an Early Plasmin Degradation Product of Human Fibrinogen, “Fragment A”, and its Clinical Application

1978 • 7 citations

Cited By (0)

Loading...
Fibrinolytic states in a patient with congenital deficiency of alpha 2- plasmin inhibitor (1980) – Blood | Metascience Observatory Explorer